BSE Live
Oct 01, 13:57Prev. Close
186.55
Open Price
186.10
Bid Price (Qty.)
193.25 (42)
Offer Price (Qty.)
193.50 (50)
NSE Live
Oct 01, 13:57Prev. Close
186.29
Open Price
186.29
Bid Price (Qty.)
193.41 (2)
Offer Price (Qty.)
193.55 (8)
Key Financial Ratios of Sequent Scientific (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 0.63 | 0.03 | -0.24 | 0.60 | 1.30 | |
Diluted EPS (Rs.) | 0.62 | 0.03 | -0.24 | 0.59 | 1.30 | |
Cash EPS (Rs.) | 0.98 | 0.38 | 0.12 | 0.98 | 1.66 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 45.65 | 43.59 | 42.43 | 41.55 | 41.45 | |
Book Value [InclRevalReserve]/Share (Rs.) | 45.65 | 43.59 | 42.43 | 41.55 | 41.45 | |
Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 | |
Revenue from Operations/Share (Rs.) | 7.12 | 6.76 | 8.93 | 8.84 | 10.69 | |
PBDIT/Share (Rs.) | 1.58 | 0.77 | 0.08 | 1.08 | 2.22 | |
PBIT/Share (Rs.) | 1.23 | 0.42 | -0.29 | 0.70 | 1.86 | |
PBT/Share (Rs.) | 0.88 | -0.01 | -0.39 | 0.63 | 1.65 | |
Net Profit/Share (Rs.) | 0.63 | 0.02 | -0.24 | 0.60 | 1.29 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 22.18 | 11.46 | 0.84 | 12.24 | 20.81 | |
PBIT Margin (%) | 17.32 | 6.15 | -3.24 | 7.87 | 17.37 | |
PBT Margin (%) | 12.36 | -0.14 | -4.37 | 7.14 | 15.40 | |
Net Profit Margin (%) | 8.86 | 0.36 | -2.73 | 6.73 | 12.09 | |
Return on Networth / Equity (%) | 1.38 | 0.05 | -0.57 | 1.43 | 3.11 | |
Return on Capital Employed (%) | 2.69 | 0.95 | -0.68 | 1.65 | 4.47 | |
Return on Assets (%) | 1.29 | 0.05 | -0.54 | 1.31 | 2.91 | |
Total Debt/Equity (X) | 0.04 | 0.04 | 0.02 | 0.02 | 0.01 | |
Asset Turnover Ratio (%) | 0.15 | 0.15 | 0.20 | 0.20 | 24.08 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 1.42 | 1.07 | 1.38 | 1.81 | 1.69 | |
Quick Ratio (X) | 1.09 | 0.72 | 0.60 | 0.97 | 1.04 | |
Inventory Turnover Ratio (X) | 5.98 | 2.49 | 1.97 | 2.18 | 5.80 | |
Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 3,317.90 | 2,921.43 | 1,829.57 | 3,325.80 | 5,987.71 | |
EV/Net Operating Revenue (X) | 18.61 | 17.34 | 8.22 | 15.14 | 22.56 | |
EV/EBITDA (X) | 83.88 | 151.24 | 972.14 | 123.67 | 108.36 | |
MarketCap/Net Operating Revenue (X) | 18.37 | 17.07 | 8.13 | 15.13 | 22.54 | |
Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Price/BV (X) | 2.87 | 2.65 | 1.71 | 3.22 | 5.81 | |
Price/Net Operating Revenue | 18.37 | 17.07 | 8.13 | 15.13 | 22.54 | |
Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
23.09.2025
22.09.2025
09.09.2025
22.08.2025
Sequent Scienti Standalone June 2025 Net Sales at Rs 41.07 crore, down 28.78% Y-o-Y
22.08.2025
Sequent Scienti Standalone June 2025 Net Sales at Rs 41.07 crore, down 28.78% Y-o-Y
21.05.2025
Sequent Scienti Standalone March 2025 Net Sales at Rs 42.33 crore, up 15.12% Y-o-Y
24.02.2025
Sequent Scienti Consolidated December 2024 Net Sales at Rs 390.81 crore, up 18.66% Y-o-Y
17.02.2025
Sequent Scienti Standalone December 2024 Net Sales at Rs 36.27 crore, down 14.06% Y-o-Y